Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein–DNA interactions

A p53 hot-spot mutation found frequently in human cancer is the replacement of R273 by histidine or cysteine residues resulting in p53 loss of function as a tumor suppressor. These mutants can be reactivated by the incorporation of second-site suppressor mutations. Here, we present high-resolution crystal structures of the p53 core domains of the cancer-related proteins, the rescued proteins and their complexes with DNA. The structures show that inactivation of p53 results from the incapacity of the mutated residues to form stabilizing interactions with the DNA backbone, and that reactivation is achieved through alternative interactions formed by the suppressor mutations. Detailed structural and computational analysis demonstrates that the rescued p53 complexes are not fully restored in terms of DNA structure and its interface with p53. Contrary to our previously studied wild-type (wt) p53-DNA complexes showing non-canonical Hoogsteen A/T base pairs of the DNA helix that lead to local minor-groove narrowing and enhanced electrostatic interactions with p53, the current structures display Watson–Crick base pairs associated with direct or water-mediated hydrogen bonds with p53 at the minor groove. These findings highlight the pivotal role played by R273 residues in supporting the unique geometry of the DNA target and its sequence-specific complex with p53.

[1]  G. Hong,et al.  Nucleic Acids Research , 2015, Nucleic Acids Research.

[2]  A. Fersht,et al.  Rescuing the function of mutant p53 , 2001, Nature Reviews Cancer.

[3]  K. Kinzler,et al.  Definition of a consensus binding site for p53 , 1992, Nature Genetics.

[4]  Emil Alexov,et al.  Rapid grid‐based construction of the molecular surface and the use of induced surface charge to calculate reaction field energies: Applications to the molecular systems and geometric objects , 2002, J. Comput. Chem..

[5]  M. J. Adams Preparation and Analysis of Protein Crystals , 1983 .

[6]  V. Rotter,et al.  Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations. , 2009, Journal of molecular biology.

[7]  Ying Wang,et al.  Structure of the human p53 core domain in the absence of DNA. , 2007, Acta crystallographica. Section D, Biological crystallography.

[8]  Thomas J Petty,et al.  An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity , 2011, The EMBO journal.

[9]  T. Halazonetis,et al.  Structure–based rescue of common tumor–derived p53 mutants , 1996, Nature Medicine.

[10]  S. Loh The missing zinc: p53 misfolding and cancer. , 2010, Metallomics : integrated biometal science.

[11]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[12]  J. Butler,et al.  Zn(2+)-dependent misfolding of the p53 DNA binding domain. , 2007, Biochemistry.

[13]  Yongheng Chen,et al.  Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer. , 2010, Structure.

[14]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[15]  M. Olivier,et al.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.

[16]  K. Malecka,et al.  Crystal Structure of a p53 Core Tetramer Bound to DNA , 2008, Oncogene.

[17]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[18]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[19]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[20]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[21]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[22]  R. Lavery,et al.  Defining the structure of irregular nucleic acids: conventions and principles. , 1989, Journal of biomolecular structure & dynamics.

[23]  A. Fersht,et al.  Structural basis for understanding oncogenic p53 mutations and designing rescue drugs , 2006, Proceedings of the National Academy of Sciences.

[24]  Shunsuke Kato,et al.  The screening of the second‐site suppressor mutations of the common p53 mutants , 2007, International journal of cancer.

[25]  K. Wiman,et al.  Pharmacological reactivation of mutant p53: from protein structure to the cancer patient , 2010, Oncogene.

[26]  B. Honig,et al.  Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs , 2010, Nature Structural &Molecular Biology.

[27]  A. Fersht,et al.  Structural biology of the tumor suppressor p53 and cancer-associated mutants. , 2007, Advances in cancer research.

[28]  R. Mann,et al.  The role of DNA shape in protein-DNA recognition , 2009, Nature.

[29]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[30]  Ting Wang,et al.  A global suppressor motif for p53 cancer mutants. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Shay,et al.  A transcriptionally active DNA-binding site for human p53 protein complexes , 1992, Molecular and cellular biology.

[32]  Magali Olivier,et al.  TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.

[33]  A. Fersht,et al.  Structures of p53 Cancer Mutants and Mechanism of Rescue by Second-site Suppressor Mutations* , 2005, Journal of Biological Chemistry.

[34]  C. Prives,et al.  Transcriptional regulation by p53. , 2010, Cold Spring Harbor perspectives in biology.

[35]  M. Oren,et al.  Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.

[36]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[37]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[38]  A. N. Popov,et al.  A quantitative approach to data-collection strategies. , 2006, Acta crystallographica. Section D, Biological crystallography.

[39]  C. Harris,et al.  The IARC TP53 database: New online mutation analysis and recommendations to users , 2002, Human mutation.

[40]  Z. Weng,et al.  A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.

[41]  M. Kitayner,et al.  Structural basis of DNA recognition by p53 tetramers. , 2006, Molecular cell.

[42]  A. Fersht,et al.  Structure–function–rescue: the diverse nature of common p53 cancer mutants , 2007, Oncogene.